mice-1
dra_schwartz / iStockphoto.com
29 March 2018Biotechnology

English appeals court overturns Regeneron transgenic mice decision

The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
Biotechnology
3 February 2016   The English High Court has revoked two European patents owned by Regeneron Pharmaceuticals covering transgenic mice.